Why the study?
Does antihypertensive therapy prevent cardiovascular morbidity and mortality in patients with hypertension?
Does antihypertensive therapy prevent cardiovascular morbidity and mortality in patients with hypertension?
This review highlights the established benefits of antihypertensive therapy in reducing cardiovascular morbidity and mortality, emphasizing its importance in the aging population.
Supports antihypertensive use in elderly hypertensives; leaves open optimal targets and agents in contemporary practice.
Hypertension is the most ubiquitous risk factor for developing cardiovascular disease, which is the leading cause of death in the United States. Results from clinical trials have established the benefit of antihypertensive therapy in preventing the morbidity and mortality associated with high blood pressure, including stroke, coronary heart disease, and heart failure. Treatment is effective in the elderly, a significant consideration because the percentage of the elderly population is growing rapidly. This article reviews the impact of antihypertensive treatment on cardiovascular disease and treatment endpoints.
No takes yet. Share an insight, caveat, or question.
Henry R. Black (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: